Risk of Secondary Cancers After CAR T Therapy May Be Similar to Risk After Other Cancer Treatments
PHILADELPHIA – The frequency of second primary malignancies (SPMs) arising in cancer survivors following treatment with CAR T-cell therapy...
Search/Filter
Loading...
Neoadjuvant Immunotherapy May Facilitate Surgery and Improve Outcomes for Patients With High-risk Liver Cancer
Patients who would not have otherwise been candidates for surgery achieved successful resection PHILADELPHIA – Patients with liver cancer...
Patients Receiving Protocol Exceptions to Participate in Targeted Therapy Trial Experienced Similar Outcomes as Eligible Participants
Study highlights potential benefits of broadening eligibility criteria for clinical trials PHILADELPHIA – Patients with treatment-refractory cancers who received...
Among Cancer Survivors, LGBTQ+ Individuals Report Higher Prevalence of Chronic Health Conditions, Disabilities, Other Limitations
Transgender or gender non-conforming cancer survivors had higher odds of most conditions compared to cisgender cancer survivors PHILADELPHIA –...
Trametinib Shows Promise for Children with Relapsed or Refractory JMML
PHILADELPHIA – The MEK inhibitor trametinib (Mekinist) was an effective treatment for pediatric patients with relapsed or refractory juvenile...
HPV Testing for Cervical Cancer May Be Safe at Longer Intervals Than What Current Guidelines Recommend
HPV testing eight years after a negative result instead of the recommended five was found comparable to standard cytology...
Outcomes After Stem Cell Transplant in Elderly Patients With Acute Myeloid Leukemia Have Improved Since 2000
Among patients over 65 who received an allogeneic hematopoietic stem cell transplant (allo-HCT) for the treatment of acute myeloid...
AACR Names New Editor-in-Chief of the Journal Cancer Prevention Research
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced the appointment of Nickolas Papadopoulos, PhD, as editor-in-chief...
FDG PET/CT Imaging After Just One Week May Predict Treatment Response in Patients With Advanced Melanoma
Following a single dose of pembrolizumab, FDG PET/CT scans were able to show metabolic changes in tumors that correlated...
Patients With Metastatic Colorectal Cancer May Continue Benefitting From Immunotherapy After Treatment Discontinuation
PHILADELPHIA – The majority of patients with metastatic colorectal cancer whose cancer did not progress during initial treatment with...